PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Althaia Xarxa Assistencial Universitària de Manresa, Escola de Doctorat, Universitat de Vic-Universitat Central de Catalunya, (UVic-UCC), Spain. Electronic address: mconstans@althaia.cat.\', \'Department of Hematology, Althaia Xarxa Assistencial Universitària de Manresa, Escola de Doctorat, Universitat de Vic-Universitat Central de Catalunya, (UVic-UCC), Spain.\', \'Laboratory Service, Althaia Xarxa Assistencial Universitària de Manresa, Facultat de Medicina, Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Spain.\', \'Hemotherapy and Hemostasis Department, IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0049-3848(21)00489-810.1016/j.thromres.2021.10.017
?:doi
?:hasPublicationType
?:journal
  • Thrombosis research
is ?:pmid of
?:pmid
?:pmid
  • 34743034
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.096
?:rankingScore_hIndex
  • 99
is ?:relation_isRelatedTo_publication of
?:title
  • Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all